Literature DB >> 10223560

Resection of brain metastases from colorectal carcinoma in 73 patients.

M Wroński1, E Arbit.   

Abstract

BACKGROUND: At the time of diagnosis of colorectal carcinoma, 2-3% of patients are likely to be harboring brain metastases, and another 10% of patients will develop brain lesions during the course of their disease. The purpose of this study was to examine the clinical course of a group of patients with metastatic brain disease who underwent surgical resection in a single institution. The authors believe this information will be useful for establishing prognostic factors and for clinical decision making.
METHODS: Between 1974 and 1993, 709 consecutive patients underwent surgical resection of brain metastases at Memorial Sloan-Kettering Cancer Center. Seventy-three patients had histologically confirmed colorectal carcinoma. The medical records of these patients were reviewed retrospectively, and the data were analyzed by univariate and multivariate analysis.
RESULTS: The median age of the 43 women and 30 men was 61.5 years. The median interval from the time of diagnosis of the primary tumor and the development of brain metastases was 27.6 months. The primary colorectal tumor was resected in all patients, and the median survival from the day of surgery was 38 months. The median survival from the time of craniotomy was 8.3 months. The 1-year and 2-year survival rates were 31.5% and 6.8%, respectively. Postoperative mortality was 4%. Gender, presence of multiple metastases, presence of lung lesions, and adjuvant brain radiation after craniotomy appeared to have no impact on survival as determined by multivariate Cox analysis. Only the presence of cerebellar brain metastases was associated with decreased survival.
CONCLUSIONS: The results of this series, which the authors believe is the largest series of resected brain metastases from colorectal carcinoma published to date, indicate that surgical resection may increase the survival of these patients. Analysis of prognostic factors shows that infratentorial tumor location is associated with a poorer survival compared with supratentorial tumor location (5.1 months vs. 9.1 months; P < 0.002). In patients with recurrent brain disease, repeated resection is a worthwhile consideration because it may prolong survival compared with patients who do not undergo re-resection.

Entities:  

Mesh:

Year:  1999        PMID: 10223560     DOI: 10.1002/(sici)1097-0142(19990415)85:8<1677::aid-cncr6>3.0.co;2-c

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  44 in total

1.  Brain Metastasis as Initial Presentation of Rectal Adenocarcinoma: an Unusual Case in a Very Young Patient.

Authors:  Jyotsana Sinha; Rong Zhang; Vinit V Patil; Miguel A Guzman; Nishant Poddar
Journal:  J Gastrointest Cancer       Date:  2018-09

Review 2.  A systematic review to assess the management of patients with cerebral metastases secondary to colorectal cancer.

Authors:  I L Silva; M Iskandarani; A Hotouras; J Murphy; C Bhan; B Adada; S D Wexner
Journal:  Tech Coloproctol       Date:  2017-11-09       Impact factor: 3.781

3.  Clinical characteristics and treatment outcomes of patients with colorectal cancer who develop brain metastasis: a single institution experience.

Authors:  Christos Fountzilas; Katherine Chang; Brian Hernandez; Joel Michalek; Richard Crownover; John Floyd; Devalingam Mahalingam
Journal:  J Gastrointest Oncol       Date:  2017-02

Review 4.  Surgical management of brain metastases.

Authors:  J S Weinberg; F F Lang; R Sawaya
Journal:  Curr Oncol Rep       Date:  2001-11       Impact factor: 5.075

5.  Brain metastases from colorectal carcinoma: a description of 60 cases in a single Chinese cancer center.

Authors:  Xiao-Bing Jiang; Qun-Ying Yang; Ke Sai; Xiang-Heng Zhang; Zhong-Ping Chen; Yong-Gao Mou
Journal:  Tumour Biol       Date:  2011-09-13

6.  Clinical features and course of brain metastases in colorectal cancer: an experience from a single institution.

Authors:  K Damiens; J P M Ayoub; B Lemieux; F Aubin; W Saliba; M P Campeau; M Tehfe
Journal:  Curr Oncol       Date:  2012-10       Impact factor: 3.677

7.  Patients with brain metastases from gastrointestinal tract cancer treated with whole brain radiation therapy: prognostic factors and survival.

Authors:  Susanne Bartelt; Felix Momm; Christian Weissenberger; Johannes Lutterbach
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

8.  Aggressive Trimodality Therapy for T1N2M1 Nonsmall Cell Lung Cancer with Synchronous Solitary Brain Metastasis: Case Report and Rationale.

Authors:  Timothy N Showalter; Alexander Lin
Journal:  Case Rep Med       Date:  2010-02-09

9.  Parkinsonism secondary to metastatic lesions within the central nervous system: a case report.

Authors:  Eduardo Hortelano; Christian Perea; Esther Uña; Amelia Cebayos; Patricia Diezhandino; Montserrat González
Journal:  J Med Case Rep       Date:  2010-07-21

10.  microRNA expression profiles in human colorectal cancers with brain metastases.

Authors:  Zhenyang Li; Xiaodong Gu; Yantian Fang; Jianbin Xiang; Zongyou Chen
Journal:  Oncol Lett       Date:  2011-11-29       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.